HOOKのROE（自己資本利益率）は？

Hookipa Pharma IncのROEは-195.24%です。

HOOKの配当利回りは？

Hookipa Pharma Incの配当利回りは0.00%です。

HOOKの品質スコア（Quality Score）は？

当社のAIはHOOKの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

HOOKは今が買い時ですか？

当社AIのタイミングスコアは100点中5点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

HOOKはどのセクターに属しますか？

Hookipa Pharma IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

HOOK (NASDAQ) 株価分析 | HOOKIPA PHARMA INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-06-12 | FS: 2025-06-30)

HOOK AI Analysis Summary

Our AI summary for HOOK: Hookipa Pharma Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -195.24%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 5/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

HOOK

Hookipa Pharma Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 1.15

0.00 (0.00%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-195.2%

ROE

-106.3%

ROA

0.00%

Div Yield

HOOKIPA PHARMA INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.15 Price 0.00 (0.00%) Day Change	NEWS SCORE: 98

HOOK, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そしてテクニカルスコアは ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.15
PBV / Sector	0.50 / 5.20 GREAT
Earning Per Share	-4.53

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	1349.852500000000
Average 1W Daily Value	0.000000000000

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

62%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-376.98 / 98.71
NPM Average (%) / Sector	-296.22 / -1,721.76
NPM Change Average (%) / Sector	30.36 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-106.26 / 27.02
ROA Average (%) / Sector	-56.16 / -368.17
ROA Change Average (%) / Sector	55.18 / 5,404.12 GREAT
ROE (%) / Sector	-195.24 / 3.47
ROE Average (%) / Sector	-95.41 / 6.51
ROE Change Average (%) / Sector	86.35 / 2,128.13 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 07:59:58
Symbol	HOOK
Name	HOOKIPA PHARMA INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	9.98 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	14.23 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 350 Fifth Avenue, New York, NY, United States, 10118

Phone: 431 890 6360

Website: https://www.hookipapharma.com

Employees: 82

Sector: Healthcare >> Biotechnology

Description: HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.